ALPHA-LIPOIC ACID MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In February 2023, Kyowa Hakko Bio announced the successful commencement of commercial production of human milk oligosaccharides (HMOs), including 2’-Fucosyllactose (2’-FL), 3’-Sialyllactose (3’-SL), and 6’-Sialyllactose (6’-SL), at their newly constructed facility in Thailand. These HMOs were slated for successive launches starting from February 2023 in regions where regulatory approvals had been obtained. Kyowa Hakko Bio is a Japan-based biotechnology company specializing in the development and manufacturing of fermentation-based products.
• In June 2021, Prinova Group LLC unveiled a new e-commerce platform designed to transform ingredient purchasing in the U.S. and Canada. The website offers live pricing, comprehensive product data on over 400 ingredients, and a personalized dashboard for real-time shipping updates, aiming to enhance customer experience by streamlining the procurement process. Prinova Group LLC is a global leader in the distribution of functional ingredients and the provision of integrated nutritional solutions for the food, beverage, and wellness industries.